Nyxoah sleep apnea neuro-stim therapy gains CE Mark
Nyxoah said it has won the CE Mark for its novel hypoglossal nerve stimulation therapy for treating obstructive sleep apnea (OSA).
The Genio system is a battery-free, leadless and minimally invasive neurostimulator designed to deliver bilateral hypoglossal nerve stimulation for moderate to severe obstructive sleep apnea patients who have failed conventional continuous positive airway pressure (CPAP) therapy.
Get the full story on our sister site, Medical Design & Outsourcing.
The post Nyxoah sleep apnea neuro-stim therapy gains CE Mark appeared first on MassDevice.
Source: Mass Device - Category: Medical Devices Authors: Nancy Crotti Tags: Blog Source Type: news
More News: Blogging | Brain | Medical Devices | Neurology | Obstructive Sleep Apnea | Sleep Apnea | Sleep Disorders | Sleep Medicine